FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today!

About | Sample | Privacy
Related Topics >> Bristol-Myers Squibb | ImClone

BMS bids $4.5B for ImClone

July 31, 2008 — 11:15am ET | By Tracy Staton
Tools

They're partners on the cancer med Erbitux, so why not join forces completely? Bristol-Myers Squibb has offered $4.5 billion for ImClone Systems, a $60-per-share price that represents about a 40 percent premium over the past month's closing prices. Release | Report

Be the first to comment
More stories about Bristol-Myers Squibb   ImClone  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 11 + 0?
To combat spam, please solve the math question above.